Inventor
JAMES R. MYETTE
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07KPeptides28%
C12NMicroorganisms or enzymes6%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
12,338,291Humanized antibody molecules to CD138 and uses thereof202512,091,451Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)202412,054,539Antibody molecules to dengue virus and uses thereof202411,945,868Antibody molecules to CD138 and uses thereof202411,136,385Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to VISTERRA INC (5)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VISTERRA INC | 5 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2021–2025 |